PBH vs PRGO
PBH: Prestige Consumer Healthcare is a branded over-the-counter consumer health products company focused on eye care, pain relief, and other wellness categories with a portfolio of established brands. PRGO: A struggling diversified consumer and prescription healthcare manufacturer navigating portfolio restructuring and strategic divestitures amid margin pressure and competitive headwinds.
Side-by-side fundamentals
| Metric | PBH | PRGO | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $49.02 | $10.47 | |
| Market cap as of 2026-07-23 | $2.3B | $1.5B | |
| P/E as of 2026-07-23 | 12.17 | n/a | |
| PEG as of 2026-07-23 | n/a | -0.00 | |
| Net margin as of 2026-07-23 | +17.5% | -43.5% | PBH higher |
| Gross margin as of 2026-07-23 | +54.7% | +34.2% | PBH higher |
| Operating margin as of 2026-07-23 | +28.4% | -36.9% | PBH higher |
| ROE as of 2026-07-23 | +10.3% | -50.6% | PBH higher |
| ROA as of 2026-07-23 | +5.5% | -19.8% | PBH higher |
| Debt / equity as of 2026-07-23 | 0.54 | 1.45 | PBH lower |
| Revenue growth (YoY) as of 2026-07-23 | -4.3% | -3.6% | PRGO higher |
| Revenue CAGR (3y) SEC XBRL | -1.2% | -1.5% | PBH higher |
| Dividend yield as of 2026-07-23 | n/a | +11.1% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.33 | 0.53 | |
| 1-year return as of 2026-07-22 close | -35.8% | -62.0% | PBH higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.